Wyatt, R. J., & Julian, B. A. (2013). IgA nephropathy. New England Journal of Medicine, 368(25), 2402–2414.
Article CAS PubMed Google Scholar
Kwon, C. S., Daniele, P., Forsythe, A., & Ngai, C. (2021). A systematic literature review of the epidemiology, health-related quality of life impact, and economic burden of immunoglobulin A nephropathy. J Health Econ Outcomes Res, 8(2), 36–45.
Article PubMed PubMed Central Google Scholar
Nair, R., & Walker, P. D. (2006). Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? Kidney International, 69(8), 1455–1458.
Article CAS PubMed Google Scholar
McGrogan, A., Franssen, C. F., & de Vries, C. S. (2011). The incidence of primary glomerulonephritis worldwide: A systematic review of the literature. Nephrology, Dialysis, Transplantation, 26(2), 414–430.
Rodrigues, J. C., Haas, M., & Reich, H. N. (2017). IgA nephropathy. Clinical Journal of the American Society of Nephrology, 12(4), 677–686.
Article CAS PubMed PubMed Central Google Scholar
Donadio, J. V., & Grande, J. P. (2002). IgA nephropathy. New England Journal of Medicine, 347(10), 738–748.
Article CAS PubMed Google Scholar
Xie, J., Kiryluk, K., Wang, W., Wang, Z., Guo, S., Shen, P., et al. (2012). Predicting progression of IgA nephropathy: New clinical progression risk score. PLOS One, 7(6), e38904.
Article CAS PubMed PubMed Central Google Scholar
Schwarzwälder, U., Hauk, M., & Zeller, T. (2009). RADAR - A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis. Trials, 10, 60.
Article PubMed PubMed Central Google Scholar
Pitcher, D., Braddon, F., Hendry, B., Mercer, A., Osmaston, K., Saleem, M. A., et al. (2023). Long-term outcomes in IgA nephropathy. Clinical Journal of the American Society of Nephrology, 18(6), 727–738.
Article PubMed PubMed Central Google Scholar
Zelmer, J. L. (2007). The economic burden of end-stage renal disease in Canada. Kidney International, 72(9), 1122–1129.
Article CAS PubMed Google Scholar
Ismail, H., Abdul Manaf, M. R., Abdul Gafor, A. H., Mohamad Zaher, Z. M., & Ibrahim, A. I. N. (2019). Economic burden of ESRD to the Malaysian health care system. Kidney Int Rep, 4(9), 1261–1270.
Article PubMed PubMed Central Google Scholar
Strauss, W. E., & Auerbach, M. (2018). Health-related quality of life in patients with iron deficiency anemia: Impact of treatment with intravenous iron. Patient Relat Outcome Meas, 9, 285–298.
Article PubMed PubMed Central Google Scholar
van Haalen, H., Jackson, J., Spinowitz, B., Milligan, G., & Moon, R. (2020). Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: Analysis of multinational real-world data. Bmc Nephrology, 21(1), 88.
Article PubMed PubMed Central Google Scholar
Hedayati, S. S., Minhajuddin, A. T., Toto, R. D., Morris, D. W., & Rush, A. J. (2009). Prevalence of major depressive episode in CKD. American Journal of Kidney Diseases, 54(3), 424–432.
Article PubMed PubMed Central Google Scholar
Zhao, Y., Chen, Y. P., Wu, Y. Q., Bao, B. Y., & Fan, H. (2020). Effect of physical activity on depression symptoms in patients with IgA nephropathy. Journal of International Medical Research, 48(1), 300060519898008.
Libório, A. B., Santos, J. P., Minete, N. F., Diógenes Cde, A., Soares, A. P., Queiroz, A. L., et al. (2012). Proteinuria is associated with quality of life and depression in adults with primary glomerulopathy and preserved renal function. PLoS One, 7(5), e37763.
Article PubMed PubMed Central Google Scholar
Canetta, P. A., Troost, J. P., Mahoney, S., Kogon, A. J., Carlozzi, N., Bartosh, S. M., et al. (2019). Health-related quality of life in glomerular disease. Kidney International, 95(5), 1209–1224.
Article PubMed PubMed Central Google Scholar
Szklarzewicz, J., & HONUS Advisory Board Members and HONUS Study Team. (2021). PO1479: Humanistic burden of rare kidney diseases; understanding the impact of FSGS and IgAN on patients and caregivers: The HONUS rationale and study design. American Society of Nephrology, Kidney Week; November 4, 2021; Orlando, FL.
ClinicalTrials.gov NCT05200871: Humanistic Burden of (FSGS) Focal Segmental Glomerulosclerosis and IgAN (Immunoglobulin A Nephropathy) (HONUS). https://classic.clinicaltrials.gov/ct2/show/results/NCT05200871?view=results. Accessed on: February 22, 2024.
Kosinski, M., Ware, J., Turner-Bowker, D., & Gandek, B. (2007). User’s manual for the Sf-12v2 health survey: With a supplement documenting the Sf-12® health survey. QualityMetric, Inc.
Peipert, J. D., Nair, D., Klicko, K., Schatell, D. R., & Hays, R. D. (2019). Kidney disease quality of life 36-item short form survey (KDQOL-36) normative values for the United States dialysis population and new single summary score. Journal of the American Society of Nephrology, 30(4), 654–663.
Article PubMed PubMed Central Google Scholar
Reilly, M. C., Zbrozek, A. S., & Dukes, E. M. (1993). The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics, 4(5), 353–365.
Article CAS PubMed Google Scholar
Spitzer, R. L., Kroenke, K., Williams, J. B., & Löwe, B. (2006). A brief measure for assessing generalized anxiety disorder: The GAD-7. Archives of Internal Medicine, 166(10), 1092–1097.
Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613.
Article CAS PubMed PubMed Central Google Scholar
National Health and Wellness Survey (NHWS) Cerner Enviza. https://www.cernerenviza.com/real-world-data/national-health-and-wellness-survey-nhws. Accessed on: December 14, 2023.
Gruenberger, J. B., Vietri, J., Keininger, D. L., & Mahler, D. A. (2017). Greater dyspnea is associated with lower health-related quality of life among European patients with COPD. Int J Chron Obstruct Pulmon Dis, 12, 937–944.
Article PubMed PubMed Central Google Scholar
Gupta, S., Isherwood, G., Jones, K., & Van Impe, K. (2015). Assessing health status in informal schizophrenia caregivers compared with health status in non-caregivers and caregivers of other conditions. Bmc Psychiatry, 15, 162.
Article PubMed PubMed Central Google Scholar
Gupta, S., Kwan, P., Faught, E., Tsong, W., Forsythe, A., & Ryvlin, P. (2016). Understanding the burden of idiopathic generalized epilepsy in the United States, Europe, and Brazil: An analysis from the National Health and Wellness Survey. Epilepsy & Behavior, 55, 146–156.
Gupta, S., Richard, L., & Forsythe, A. (2015). The humanistic and economic burden associated with increasing body mass index in the EU5. Diabetes Metab Syndr Obes, 8, 327–338.
Article PubMed PubMed Central Google Scholar
Gupta, S., Ryvlin, P., Faught, E., Tsong, W., & Kwan, P. (2017). Understanding the burden of focal epilepsy as a function of seizure frequency in the United States, Europe, and Brazil. Epilepsia Open, 2(2), 199–213.
Article PubMed PubMed Central Google Scholar
Pavord, I. D., Mathieson, N., Scowcroft, A., Pedersini, R., Isherwood, G., & Price, D. (2017). The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β(2)-agonists in the United Kingdom: A cross-sectional analysis. NPJ Prim Care Respir Med, 27(1), 17.
Article PubMed PubMed Central Google Scholar
Strader, C., Goren, A., & DiBonaventura, M. Prevalence of combinations of diabetes complications across NHANES and NHWS. 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE); August 26, 2016; Dublin, Ireland.
Kalton, G., & Flores-Cervantes, I. (2003). Weighting methods. J off Stat, 19(2), 81.
Hays, R. D., & Morales, L. S. (2001). The RAND-36 measure of health-related quality of life. Annals of Medicine, 33(5), 350–357.
Article CAS PubMed Google Scholar
Stuart, E. A. (2010). Matching methods for causal inference: A review and a look forward. Stat Sci, 25(1), 1–21.
Comments (0)